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• What are patients’ views on the collection of quality of life data during treatment 
for early-stage lung cancer? 
• Technology literacy may limit the online data capture. Patients prefer treatment-
specific questionnaires   
• Quality of life data collection is important for patients and may help facilitating 
discussions in clinical consultation 
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There is increasing interest in quality of life evaluation following Video-Assisted 
Thoracoscopic anatomical lung resection or Stereotactic Ablative Body Radiation 
Therapy for early-stage non-small cell lung cancer. A qualitative interview study was 
conducted to gain insight into the optimal methods of assessing and discussing quality 
of life in clinical practice. 
Methods 
A prospective observational longitudinal study of early stage non-small cell lung 
cancer patients was conducted where repeated quality of life measures were 
administered either online or on paper. 
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A subset of participants were invited for qualitative interviews after the 6-month 
assessment or at the end of the study. The semi-structured interviews were 
transcribed verbatim and thematically analysed. 
Results 
Twenty-three patients were interviewed.  Generally, patients were content with 
recruitment and data collection procedures. Most opted to complete the assessments 
on paper instead of online, this choice was influenced by level of technology literacy. 
Some found the questionnaires too generic to reflect their experiences. Barriers to 
questionnaire completion were mostly practical, and many acknowledged benefits of 
quality of life assessment including allowing them to express problems and health 
issues, and following changes over time.  Generally, participants would like to discuss 
quality of life results during clinical consultations, but reported this rarely happened. 
Conclusion:  
Lung cancer patient interviews confirm the acceptability of repeated quality of life 
assessments, but online data capture is limited. Patients highlight the importance of 
discussing quality of life aspects with their clinical team. Future strategies are needed 




NSCLC: Non-small cell lung cancer 
SABR: Stereotactic ablative radiotherapy 
VATS: Video-Assisted Thoracoscopic Surgery 
QoL: Quality of Life 
COREQ: Consolidated Criteria for Reporting Qualitative Research  
Lilac: Life after Lung Cancer Study 
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NHS: National Health Service 
IT: Information Technology 
EORTC: European Organization for Research and Treatment  
QLQ C-30: Quality of Life Questionnaire  
GP: General Practitioner 




Lung cancer is the third most common cancer in the UK, accounting for 13% of all new 
cancer cases (2015)[1]. If identified at an early-stage (Stage I-II), surgical resection of 
Non-Small Cell Lung Cancer (NSCLC) offers a favourable prognosis, with five-year 
survival rates from 90% for Stage IA to 65% for Stage IIA[2]. Although treatment 
guidelines recommend objective thresholds to estimate the surgical risk of lung 
resection[3], the main concern for patients is not the immediate mortality or 
complications, but rather the permanent disability and loss of independence post 
treatment which impacts greatly on patients’ quality of life (QoL). A survey among 
European thoracic surgeons revealed a lack of standardised QoL collection among 
this community with only 12% of all surgeons currently incorporating these outcomes 
into their clinical practices [4]. 
The advent of Stereotactic Ablative Radiotherapy (SABR) for peripherally located 
NSCLC, as a non-surgical radical treatment for patients medically unfit for surgery, 
has further highlighted the need for more patient-centred data to inform treatment 
decision-making [5, 6]. SABR is a relatively recent technique implemented in lung 
cancer care but more QoL data are becoming available to allow comparison with 
surgical cohorts [7, 8].   
Psychological wellbeing is very important to early-stage lung cancer patients, who 
have highlighted the need to incorporate this aspect of QoL into the pre- and 
postsurgical discussions[9]. Lung cancer patients rate independence and QoL as 
more important compared to survival or cancer recurrence when discussing treatment 
options [10]. Participants were willing to accept high periprocedural mortality, but not 
severe deficits in QoL when considering treatment. 
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 Focusing on patients’ values and preferences regarding treatment decisions is 
essential, but at present we do not know the best way to discuss and routinely assess 
QoL in this patient group throughout the diagnosis, treatment and follow-up care 
trajectory. 
With longitudinal assessments of QoL, attrition is a common issue that can affect 
generalizability of findings [11]. The reported attrition rates in lung cancer studies vary 
considerably and only few studies to date document the pattern of, and reasons for 
dropout [12]. A recent review on QoL assessment in early stage NSCLC patients 
revealed particular difficulties with the pre-treatment assessment, hampering 
effectiveness analysis [13]. 
It has been also argued that the existing tools may not be sensitive enough to be useful 
in the clinical non-research setting[14]. 
Electronic reporting of QoL and symptoms had the potential to significantly improve 
data collection in lung cancer patients. It could reduce burden for patients (travel time 
and costs), and lead to more complete data capture at a lower cost to hospitals [15].   
In our prospective observational study of patients undergoing treatments for early 
stage NSCLC, we aimed to determine the feasibility and patient acceptability of online 
self-reporting of patient-reported outcomes (Lilac study-Yorkshire Cancer Research 
Grant L399[16]). A subset of participants took part in qualitative interviews to explore 
opinions on routine assessment of QoL in the study and wider views of QoL 
discussions in clinical practice. In particular, our interviews aimed to explore patients’ 
views on the practical aspects of taking part in the study and on how this participation 
influenced the clinical experience. 
Here we report the findings from these interviews, which provide insight into the 
optimal methods of assessing and discussing QoL in clinical practice.  
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2 Material and Methods: 
2.1 Sample and procedure 
This qualitative study was embedded within the Life after Lung Cancer (Lilac) project, 
a prospective observational longitudinal study utilising repeated QoL measures. 
Patients undergoing treatments for early stage NSCLC (Video-assisted 
Thoracoscopic-VATS anatomical lung resection or Stereotactic Ablative Body 
Radiation Therapy-SABR) who were not involved in other QoL studies were 
consecutively recruited from the Leeds Teaching Hospitals NHS Trust. All participants 
signed a written consent form and the study received ethical approval from The 
National Research Ethics Service Yorkshire and the Humber-Leeds East Committee 
(REC Ref: 16/YH/0407). Recruitment took place between February 2016 and March 
2017. QoL data were collected through the administration of the European 
Organization for Research and Treatment (EORTC) Quality of Life Questionnaire 
(QLQ C-30)[17] and its Lung Cancer specific Module (LC-13)[18] at baseline, 6 weeks, 
3, 6 and 12 months follow-up. Participants had the option of completing questionnaires 
on paper or online. Full details of the study protocol have been published 
previously[16]. A subset of patients was invited for qualitative interviews after the 6-
month assessment (interim interviews, performed to guide potential adjustments to 
the project methodology) or at the end of the study. For interim interviews we used 
consecutive sampling with an aim to interview three patients from each treatment 
group with representation from both online and paper completers. For end of study 
interviews we used purposive sampling for sex, age, and mode of questionnaire 
completion. Interviews were semi-structured and lasted approximately 40-60 minutes, 
taking place either in the hospital over the phone or at a location of the participant’s 
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preference. When interviews were performed face-to-face, participants were 
presented with the QoL questionnaires to facilitate the interview. 
Interviews were performed until data saturation occurred [19]. Interviews were audio 
recorded, and transcribed verbatim by an external professional company.  
 
2.2 Interviews  
 
The full semi-structured interview schedule is presented in the Supplementary Table1. 
Patients were asked to comment on two main topics: Lilac study procedures and the 
impact of the QoL collection on their clinical experience. Detailed questions about 
recruitment procedures were added in response to initial recruitment issues in the pre-
surgical setting. Patients were asked for views on their choice of either paper-based, 
or online questionnaire completion and their IT literacy. Interviews were performed by 
three members of the research team, none of whom were involved in the clinical care 
of participants (CP, Thoracic surgeon and research fellow on the study; BC research 
nurse and ES research assistant).  
 
2.3 Data analysis and reporting 
 
We used the framework approach to thematic analysis [20, 21]. The coders (CP and 
FWB) independently read transcripts several times to familiarize themselves with the 
content, and highlighted sections related to the research aims. 
These were independently coded into key issues and themes, forming an initial basic 
coding framework. Following coding of the first three interviews, the framework was 
reviewed and amendments made in accordance with the content of the interviews (i.e., 
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to allow further themes and subthemes to emerge from the data). Thus, an iterative 
approach was adopted so that changes could be made to the framework as new 
themes and relationships between themes emerged. Regular meetings were 
scheduled to discuss any queries or discrepancies, and these were resolved by 
discussion to reach a consensus. Finally, one coder (CP) examined all transcripts 
again to ensure robustness of the analytical process. The consolidated criteria for 
reporting qualitative research (COREQ)[22] were used in this report. All quotes 





For the interim interviews, six patients were approached consecutively after being on 
study for at least six months. As distribution of participants’ questionnaire completion 
mode was skewed (less than 10% of the initial participants completed the 
questionnaire online), we interviewed three patients face-to-face at this stage (one 
online and two paper completers). Three patients declined (dealing with post-surgical 
issues (N=1), no reason provided (N=2). For the end of study interviews, 37 patients 
were approached of whom six declined (feeling overwhelmed (N=2), lack of time 
(N=2), or no reason provided (N=2)). Eleven patients could not be reached over the 
phone after three attempts. Within the end-of study interview samples, data saturation 
started after 18 interviews with no further additional themes being identified. Two 
additional interviews were conducted to ensure we had reached data saturation. A 
final sample of 20 patients took part in end of study interviews, seven were interviewed 
in person and the remaining over the phone. More than half of participants were female 
(N=12), mean age 74 years, range 42-84. Eight patients received SABR treatment 
and 12 received surgical resection, reflecting the proportion of treatment groups 
recruited for the full study.  
3.2 Interim Interviews 
Interim interview analysis highlighted that the schedule was primarily directed towards 
exploring experiences with electronic completion of questionnaires, which precluded 
capturing patients’ wider experiences related to repeated collection of QoL data. 
Appropriate changes to the schedule, including additional questions about the reasons 
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for preferred completion mode, were made before continuing with further interviews. 
Questions were added to capture patients’ views of clinician’s use of the QoL data 
linked to the electronic medical records in consultations, which emerged as an 
important factor from interim interviews.  
 
3.3 End-of-study interviews 
 
Four main themes were identified in relation to patient engagement with routine 
completion of patient-reported outcomes and the benefits of the QoL data collection 
in clinical practice (Table 1). 
 
3.3.1 Recruitment and consent process.  
Patients were generally very satisfied with the face-to-face Lilac consent process.   
 
“I preferred it that it was personal rather than through a letter or something like that.” 
(Female +70Y SABR) 
 
Five patients were happy for a doctor to first introduce the research study, feeling 
reassured that they were aware of what was happening at that moment in time. 
However, patients could not recall in too much detail what was initially discussed 
though they did feel that they were appropriately invited to participate and that the 
study was explained well. 
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“I’m glad he did ask because he knew what he was talking about.”  (Female +70Y 
Surgery) 
 
 “You know the day you see the surgeon and discuss all about what they’re going to 
do, and then asked if you’d do the survey, I think it’s the only way you can do it.” 
(Female +70Y surgery) 
 
The timing of recruitment, shortly after the patient had received their diagnosis, 
presented some difficulties. Five patients indicated that they had received traumatic 
news and that it was difficult to concentrate on other things.  
 
  “when somebody tells you that you, 'we're treating you for cancer of the lung' you 
don't think about research... You're thinking about yourself a little bit and no, I mean I 
just went along with whatever they approached me with” (Male, +70Y surgery) 
 
This was particularly emphasised by surgical patients. One patient however, indicated 
that the study was perceived as a welcome distraction from this difficult moment. 
 
3.3.2 Barriers and facilitators of completion methods  
Patients completing questionnaires on paper, frequently mentioned that their choice 
was driven by the fact that they found it easier to access, and that it allowed them time 
to sit down, have the piece of paper in front of them, and reflect.  
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“At my age, I think I find it easier to do things on paper where I can actually see and 
then if you go wrong when you’re doing it online, it kicks you back to the beginning or 
it won’t let you carry on” (Female +70Y SABR) 
 
Patients choosing the online completion method reported they generally found this 
method easier. One patient explained their handwriting is difficult to read, others 
reported choosing the online method for ecological reasons. One participant who tried 
the online method found it irritating to not have the possibility to skip questions and 
come back to them later. 
Thirteen out of twenty patients interviewed did not consider themselves to have a good 
level of Information Technology (IT) literacy. Either they did not have access to internet 
or, if they did, they did not frequently use it. One patient reported being apprehensive 
about using online medical advice or websites. Another patient reported that because 
of her age she didn’t feel skilled enough to complete the questionnaire on the 
computer. 
 
“I’ve got a mobile phone but I don’t, I just use it for calls and I don’t ever use the Internet 
really” (Female <70Y Surgery) 
 
“Because the only line I've got, love, is a washing line” (Male +70Y SABR) 
 
One online participant described how his granddaughter supported him to complete 
the questionnaires.  Three others however, said they were not keen to ask family for 
help in completing the questionnaires although they were aware their family members 
do have access to internet. Despite this limited level of IT literacy overall, five patients 
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reported using the internet to access their General Practitioners (GP) practice’s online 
services. 
3.3.3 Engagement with the QoL Study (Lilac) 
Almost all patients (19/20, 95%) considered that receiving reminders to complete the 
questionnaires helped them remember to complete the questionnaires. Preferred 
methods for reminders varied from person to person and included phone calls, text 
message or emails.  
 
“I'm happy online but I think you have to do both because some older people are not 
very happy using the internet. So, for me, you can send me an email, I'm quite happy 
to go that way…I'm sort of technologically minded...but a lot of people are not” (Female 
+70Y SABR) 
 
One patient highlighted the fear of phishing calls, having lost trust in people ringing for 
commercial reasons. 
 
In general, patients were happy with the frequency of the questionnaires. Two patients 
mentioned the difficulty in completing the first one, six weeks after treatment. They 
explained that this was a busy period where most of the post-treatment complications 
occurred. One patient suggested having another questionnaire at 18 months after 
treatment, and another participant preferred more frequent assessments in general to 
better discriminate symptoms over time. 
 
“I was just getting over the operation because my heart played up a little bit, so I had 
a few complications and the district nurse was coming, and then when that first 
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questionnaire come through, it took me, I think it were three or four days before I could 
actually figure out, that I felt like I could do it” (Female +70Y Surgery) 
 
Patients identified several barriers in completing the questionnaires: three patients 
reported they did not receive some surveys, two acknowledged they had lost it, and 
two patients identified their health issues were a barrier to completion. 
Facilitators to completing the questionnaires included that answering the questions 
allowed them to express problems and health issues. They also highlighted the 
importance of completing these measures to capture QoL changes over time. 
Patients especially indicated that it helped them to feel reassured that someone was 
looking after them. One patient even stressed that it was way to share the burden and 
psychological issues. 
 
“Because like in-between these questionnaires I’ve spoken to other people as well, 
you know, and I liked see how far I’ve come and that. Yeah, when I’ve filled one 
questionnaire in and then I filled another one at three months, I felt “oh I’m getting 
better here” (Female <70Y Surgery) 
 
“I think it was a good way, sort of like you are sharing your, you know, sorrows and 
your pain with, you know, through paper” (Female <70Y Surgery) 
 




Patients were satisfied with the content of the questionnaires in general, but four 
responders indicated that not all questions applied to them, or were too generic. 
Suggestions included adding free text space so they could indicate whether the 
symptom was related to the lung cancer treatment, for surgery-related notes, 
medications, and other health conditions.  Patients under 50 years also suggested 
including specific questions about family life.  
 
3.3.4 Perceived influence of quality of life assessment on clinical care 
Most patients (14/20, 70%) indicated they did not discuss QoL with the clinical team. 
They thought doctors’ busy schedules was one reason behind this. A patient explained 
that in clinic, questions are largely focused on health issues rather than overall 
wellbeing. However, one patient expressed that they would have probably had fewer 
clinic appointments if QoL was discussed in the consultation.   
 
“it won’t take 10 minutes or something like that because I appreciate people are very, 
very busy. But I think a lot of, after telephone, visits and things, could be avoided if a 
few caring questions could be asked” (Female +70Y Surgery) 
 
“No, I didn't, I just discussed about walking and that” (Female +70Y Surgery) 
 
All the patients but one said that the QoL data collected during the study, was not 




The aim of this work was to explore patients’views and experiences with our research 
study which focussed on the collection of QoL data, and its impact on patients’ 
experiences of care. On the whole, the study setup and procedures were accepted by 
patients, with positive feedback provided on the recruitment and consent process. 
Generally, patients preferred a face-to-face invitation to take part in the study with 
reminders sent through the post or via text.  
Online data capture proved difficult due to the low level of IT literacy and older age of 
patients. While some patients had access to support from family members, many 
reported not wanting to burden their families for help with online questionnaires. This 
may explain contrasting findings in our sample compared to other studies conducted 
by our wider research team involving patients with breast, ovarian and colorectal 
cancers [23, 24].Our participants supported keeping the paper-modality as an option 
for older people in future studies in lung cancer. Other studies among e.g., colorectal 
cancer patients and women undergoing screening mammography have similarly 
concluded that paper-based questionnaire completion still seems preferred by older 
groups [25, 26].  
Although the questionnaires used in the study (EORTC QOL C-30 and LC-13) were 
carefully selected as cancer specific and internationally validated measures, they were 
not able to capture specific issues related to surgery or SABR. Patients were 
concerned about questions being too generic, calling for additional notes to explain 
their answers. The updated version of the LC-13 questionnaire, where tailored 
treatment-related questions will be included, may help in overcoming these issues 
[27]. 
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While the majority of patients perceived the completion of the questionnaires as 
improving self-awareness of their QoL and providing valuable additional information 
to share with their clinical team, the results of QoL data were rarely discussed during 
clinic consultation by patients or clinicians. These results are in line with the work of 
Powel and colleagues where early stage lung cancer surgical patients reportedly 
deferred decisions about treatment to their medical team [28]. Of note, the Lilac study 
was not designed to study the clinician’s use of the QoL data in clinical practice. 
Instead, we tried to gain insight from patients on how the QoL discussion would have 
helped to understand better how the patient was recovering after treatment. Although 
clinicians were introduced to using the QoL data real time in clinics, more efforts and 
studies are needed to improve uptake and integration of Patient-Reported Outcomes 
Measures (PROMs) within electronic patient records.   
Limitations 
Our study has several limitations. Purposive sampling for qualitative research captures 
the diversity of the population to sufficiently describe the phenomenon of interest [29]. 
We acknowledge that the views of our participants may differ from those who declined 
to take part. Our study has also been characterized by limited participation of the 
electronic completers, possibly limiting the generalizability of the results. 
Recruitment was based on a sample of lung cancer patients participating in the Lilac 
study. Demographic data collected did not include race/ethnicity or sociodemographic 
status of participants. We included patients from one regional hospital, so the results 
may not be widely applicable to other settings, regions or patient groups. A range of 
other variables such as cultural differences, travel distance, clinic wait times, 
interactions with non-clinical staff, may also influence participant recall and responses. 
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We did not directly observe patient–clinician interactions, so our findings may not 
reflect actual practice. As is the case for many qualitative studies, our results are 




In conclusion, this study suggests that our study population of lung cancer patients 
have a relatively low level of IT literacy, limiting the potential of online QoL data 
capture. This is something we can expect to change in coming years, with increasing 
use of technology in older populations, and availability of accessible technological 
platforms. To increase the uptake and use of QoL data by clinicians, more effort should 
be directed towards providing training to doctors and nurses in utilising patients’ QoL 
data in practice. Most importantly, these qualitative interviews have highlighted the 
importance for patients to discuss QoL aspects with their clinical team – not just when 
issues are present, but also when things are going well. This underscores the need 
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Table 1: Themes and subthemes 
Table 1 
Consent process Introduction to the study 
Timing of invitation 
Psychological situation 
Member of the staff 
Completion methods: barriers 
and facilitators 
Perceived facilitators for paper completion  
Perceived facilitators for online completion 
Perceived barriers for paper completion 
Perceived barriers for online completion 
Computer/Internet use 
Family support for Lilac participation 
Patients engagement with Lilac Reminder preferences 
Frequency of assessment 
Barriers to complete questionnaires 
Questionnaire role in expressing symptoms/issues 
Comments on questions and suggestions 
Perceived influence on clinical 
care 
Involvement of clinicians in quality of life discussion  
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